CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia. (Q44846741)
Jump to navigation
Jump to search
scientific article published in January 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia. |
scientific article published in January 2006 |
Statements
CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia (English)
Lau JS
Wong KF
1 reference
1 reference
1 reference
1 reference
1 reference